Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT02992392 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2016-12-15
Summary
With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte application on the lipid and stability of the tear film in dry eye patients.
Conditions
- Dry Eye
Interventions
- DRUG
-
Liposic
one eye of the participant recieved Lipoic
- DRUG
-
Tears Naturale Forte
the other eye of the participant recieved Tears Naturale Forte
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Xingwu Zhong · Zhongshan Ophthalmic Center, Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-06-30
Countries
- China
Study Locations
More Related Trials
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of HE10 for Dry Eye Syndrome
NCT02492412 ·Status: COMPLETED ·Phase: PHASE3
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
NCT02011776 ·Status: COMPLETED
-
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects
NCT01718028 ·Status: COMPLETED ·Phase: NA
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK
NCT07097922 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
NCT02470429 ·Status: COMPLETED ·Phase: NA
-
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
NCT04280653 ·Status: COMPLETED ·Phase: NA
-
Effects of Dry Eye Treatments on the Ocular Surface
NCT01797822 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
NCT05467293 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation on Medical Management of Dry Eye Patients
NCT01942226 ·Status: COMPLETED
-
A Randomized Study of Smile Exercise for Dry Eye
NCT04421300 ·Status: COMPLETED ·Phase: NA
-
Dry Eye Treatment With Artificial Tears
NCT02420834 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease.
NCT06633471 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye
NCT06752278 ·Status: COMPLETED ·Phase: NA
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 ·Status: COMPLETED
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2